New York Mets’ Robinson Cano banned for a year due to PED

New York Mets second baseman Robinson Cano has tested positive for stanozolol, a performance-enhancing drug, and will be suspended for the entire 2021 season, according to a statement from Commissioner Rob Manfred.

This is the second PED suspension for Cano, 38, who missed 80 games in 2018 after testing positive for a diuretic with the Seattle Mariners.

A second positive test results in an automatic 162-game suspension, according to the joint drug agreement between Major League Baseball and the MLB Players Association. Cano will lose his $ 24 million salary.

Cano was traded to the Mets in a now fateful December 2018 deal that sent top prospect Jarred Kelenic to the Seattle Mariners. After struggling in his first season with the team, he rebounded to reach .316 / .352 / .544 this season and was expected to play an important role as the Mets play their first season under new owner Steve Cohen. and the new management of the front office. .

Cano, who signed a 10-year, $ 240 million contract with the Mariners, has two years and $ 48 million remaining on his contract. The Mariners will pay $ 7.5 million.